Autopsy report · NCT01527747

Effects of DPP-4 Inhibition on Triglycerides

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Funding”

The sponsor’s own words in the registry.

Life of this trial

Suspended: paused, and may or may not restart.
15 participants enrolled.

Vital statistics

Status: Suspended
Phase: Phase 4
Sponsor: Oregon Health and Science University
Sponsor type: University, hospital or other
Conditions: Type 2 Diabetes; Hypertriglyceridemia
Interventions: Saxagliptin
Participants: 15
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.